INTRODUCTION
Though genome wide association studies (GWAS) have identified numerous genetic polymorphisms associated with increased risk of disease, the function of these variants remains largely unknown.
Just as 99% of the human genome is non-coding sequence, the vast majority of GWAS identified risk associated single nucleotide polymorphisms (SNPs), and SNPs with which they are in high linkage disequilibrium (LD), are located within the non-coding region of the genome (1-3). They are enriched in regulatory regions of the genome and may alter regulatory elements and expression of nearby genes based on studies on epigenetics and expression quantitative trait loci (eQTLs)(2-7). Consistent with this, SNPs in regulatory regions appear to be under evolutionary constraint (8) . Experimental validation of this hypothesis has been restricted to a few targeted examples (9) (10) (11) (12) (13) (14) (15) (16) (17) (18) (19) . A recent loss-offunction screen in 501 cancer cell lines revealed that 82% of cancers depend on RNA expression level(20), far exceeding mutations and copy number changes, underscoring the importance to study the role of cancer risk variants in gene expression.
Prostate cancer, the second leading cause of cancer-related death in men in the United States, is a good model to investigate the mechanism through which common variants influence disease risk.
Prostate cancer is highly heritable, as evidenced by increased rates of comorbidity among monozygotic twins compared to dizygotic twins(21-23). To date, approximately 100 independent risk SNPs have been identified (24) . These variants tend to be associated with gene expression changes in normal prostate tissue, prostate cancer, and prostatic secretions (25) (26) (27) (28) (29) (30) and are found more often in prostatic regulatory regions (31, 32 (30) . Rs10993994 is in a 33kb LD block, within which we had also found a second SNP, rs7098889, that is associated with β -MSP levels in prostate tissue independent of rs10993994 (30) .
With the advent of genome editing tools in mammalian cells such as CRISPR/Cas9(34), it is possible to envision testing a large number of loci for their effect on target gene expression and phenotype.
Here, we have chosen to use the highly efficient paired gRNA system (34, 35) to delete a candidate regulatory region. This way, in a heterozygote cell line, we can disentangle the effect of each of the two alleles. Here, we apply this system to rs10993994 and rs7098889. We demonstrate that each of these SNPs, located in the most prostate-specific enhancer region, independently and greatly alters MSMB expression in an allele-specific manner. We further show that these SNPs have no substantial effect on the expression of NCOA4, nor do they have a direct effect on the prostate secreted proteins hK2 and PSA. These data demonstrate that a single SNP can have a large effect on gene expression and illustrate the importance of functional validation to deconvolute observed correlations. The method we have developed is generally applicable to test any SNP for which a relevant heterozygous cell line is available.
MATERIAL AND METHODS

CRISPR/Cas9 mediated genome editing with paired gRNAs
We designed paired guide RNAs flanking either the rs7098889 (rs7098889-g1 and rs7098889-g4, Supplementary 
Genomic PCR and identification of isogenic allelic deletion by Sanger sequencing
Genomic DNA was extracted from bulk transfected LNCaP or AGS cells upon completion of puromycin selection using DNeasy kit (Qiagen, Germany), or from LNCaP single clones derived from the bulk transfections. Deletion was confirmed by PCR amplification using primers flanking the deletion region, rs7098889-For1 and rs7098889-Rev1 for rs7098889 site (Supplementary Table 1, synthesized by Invitrogen); and rs10993994-F1 and rs10993994-R1 (Supplementary Table 2 
Western blot
Cells from six-well plates were collected by cold PBS, whole cell lysate were prepared using cold 
Single cell cloning
Upon completion of puromycin selection, bulk PX458-rs7098889-g1 and PX459v2-rs7098889-g4
transfected LNCaP cells or the bulk PX458-rs10993994-g4a and PX459v2-rs10993994-g4b
transfected LNCaP cells were plated into 96-well plates (Falcon) by serial dilution. Cells were cultured in LNCaP condition medium filtered by 0.22µm Millex membrane (Millipore) until colonies starting form in about 3 weeks. Single clones were then trypsinized and transferred to 24-well plates followed by 6 well plates in triplicates, and used for genomic DNA extraction followed by PCR and Sanger sequencing genotype identification, freezing clones, and future experiments, respectively.
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Allelic expression analysis
Total RNA was extracted from bulk transfected LNCaP and validated single clones, followed by reverse transcription (High Capacity cDNA Reverse Transcription Kit, Applied Biosystems #4368814), cDNA then amplified by PCR reaction with primers flanking MSMB 360A/T site. Agarose gel purified PCR products were then subjected to Sanger sequencing by Genewiz and returned chromatogram sequence were visualized in 4Peaks.
RESULTS
Rs7098889 is found in the most prostate-specific enhancer
To determine the causal allele(s) for prostate cancer associated risk SNPs we hypothesized that causal variants would likely be present in prostate specific regulatory elements. Using data on active enhancers from the FANTOM5 consortium analysis of enhancer RNAs (5) (http://slidebase.binf.ku.dk/human_enhancers/selector), we found that the most prostate specific enhancer is located 5kb upstream of the MSMB promoter and overlaps rs7098889 (Table 1 ; Figure   1 ).
CRISPR/Cas9 mediated deletion of the region flanking rs7098889 leads to significant increase of MSMB expression in LNCaP cells
We therefore used paired gRNA mediated CRISPR/Cas9 deletion to remove the 191bp region flanking rs7098889 in two heterozygous cell lines --LNCaP (prostate cancer) and AGS (gastric cancer) ( Fig. 2A and Fig.2B ). Efficient deletion of the region was confirmed by genomic PCR (Fig.   2B ), though we noted another variant (rs4304716, r 2 =0.87 with rs7098889) in this deletion region as well. We next examined gene expression levels in these bulk transfected cells and found that MSMB exhibited 9.5-fold overexpression after deletion of this regulatory region in LNCaP, but not in AGS (Fig. 2C) . In contrast, NCOA4, whose expression is associated with rs10993994 and rs7098889 in GTEx eQTL data(7), was not significantly altered after deletion. Similarly, neither KLK2 (codes for hK2) nor KLK3 (codes for PSA) levels were altered after deleting this element (Supplementary Fig. 1 and 2). The over-expressed transcripts were translated into β -MSP protein and secreted from LNCaP ( Fig. 2D and Fig.2E ). These data suggest that rs7098889 is located at a regulatory region that strongly and specifically regulates MSMB expression in prostate tissue.
Rs7098889 T allele, but not the C allele, confers about 300-fold increase of MSMB expression
We next generated single-cell clones from the transfected cells and identified derivative lines that have each of the possible genotypes -del/del, del/T, and del/C -by titrating the transfected plasmids expressing gRNAs/Cas9 to reduce efficiency and increase the chance of getting heterozygous clones ( Fig. 3A and Fig. 2B ). Again, in the bulk transfected cells there is a dramatic increase in MSMB expression (Fig. 3C) . Sub-cloning of these cells followed by Sanger sequencing (Supplementary File 1) confirmed three T clones (T/del for clone 3, 4, 5), two C clones (C/del for clone 6, 7), as well as two clones with homozygous deletion (del/del for clone 1, 2). Since LNCaP is aneuploid, we also included 7 the upper bands for genotyping to ensure no additional copies of the intended target allele remained.
Surprisingly, for every single clone we analyzed, the remaining alleles were always identical (either T or C) at locus rs7098889 (Supplementary File 1).
Two out of three of the T clones (clones 4, 5) express MSMB close to 300 fold higher than baseline (Fig. 3C) , while no overexpression is observed in the C clones (clones 6, 7). In the case of the double deletion, one of the two clones overexpressed MSMB. To the best of our knowledge, this is the first example of a GWAS-identified risk SNP that unequivocally shows such dramatic effect on gene expression in a highly tissue specific manner. Notably, this effect is very specific to MSMB expression alone, as no significant change in adjacent NCOA4 expression is observed, nor is a trans effect on expression of KLK2 or KLK3 present (supplementary Fig. 2 ).
Allele specific expression of MSMB in LNCaP cells
A single nucleotide variant (SNV) 360A/T unique to and heterozygous in LNCaP was identified by
Sanger sequencing in the last exon of MSMB. We used this SNV as a marker to trace allelic origin of the transcripts. Overexpressed MSMB transcripts from all MSMB high expression clones (clones 2, 4, 5) and the bulk LNCaP cells all came from the 360T allele (Fig. 4B) . The control LNCaP parental cells and the empty vector control only express very low basal level of MSMB. In these cases, the transcripts come from both alleles (Fig. 4B , 360A/T)
Rs10993994 C allele, but not the T risk allele, also confers significant MSMB over-expression
Previous work at this locus suggested that rs10993994 may be the causal SNP for prostate cancer risk as it localizes in the promoter region of MSMB and alters the ability of the promoter to drive expression in a reporter assay (33, 37) . Thus, we performed a similar CRISPR/Cas9 mediated genome editing experiment to validate its role in the regulation of MSMB gene expression (Fig. 5A ).
We deleted a 205bp region flanking rs10993994. In the bulk transfected LNCaP cells, this deletion results in 2.8 fold overexpression of MSMB (Fig. 5B) . No overexpression was observed either in the gastric cancer AGS cell line or of the immediate downstream NCOA4 gene (Fig. 5B ). Single cell clones were then generated from the bulk transfected LNCaP cells and resulted in three heterozygous clones with the C allele deletion (T/del for clone 2, 3, 4); three heterozygous clones with T allele deletion (C/del for clone 5, 6, 7); and one clone with homozygous deletion (del/del for clone 1). Even though the deletion removed the majority of the MSMB promoter including the TATA box (Supplementary File 2), significant overexpression of MSMB was observed in two of the three C/del clones ( Fig. 5C ), potentially by transcription from an alternate promoter. Such overexpression was not observed in any of the T/del or del/del clones. Also, we did not observe substantial change of NCOA4, KLK3 and KLK2 gene expression in any of these clones ( Supplementary Fig. 3 ). The result suggests the existence of a strong transcription repression mechanism mediated through both the rs7098889 and the rs10993994 loci. Furthermore, the fact that both loci have dramatic effects on MSMB expression in prostate tissue supports the hypothesis that the association of these SNPs with prostate cancer risk is mediated through their regulation of MSMB gene expression.
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DISCUSSION
Here, we have unequivocally demonstrated dramatic allelic effects on MSMB expression at two prostate-cancer associated SNPs. Notably, despite these two SNPs being in strong linkage disequilibrium in European populations, each SNP appears to independently influence MSMB expression. One can imagine a model in which it is the set of alleles on a haplotype, each exerting an effect, that leads to the observed phenotype rather than the typically assumed model in which there is a single causal allele in LD with other SNPs. Consistent with this hypothesis, reporter assays based on phenotype-associated human haplotypes have demonstrated such additive effects as well (38) .
Previous correlative work had implicated both MSMB and NCOA4 as target genes of rs10993994 and potential mediators of the SNP's effect on prostate cancer risk (25) , though studies of protein expression found that rs10993994 is only associated with β -MSP, and not NCOA4, expression(39).
Our results demonstrate that regulatory regions encompassing both rs10993994 and rs7098889
directly affect the levels of MSMB only and have no effect on NCOA4. MSMB codes for β -MSP, a major secretory product of the prostate. It is widely secreted by multiple mucosal tissues (40) and has been proposed to manifest both fungicidal activity(41) and tumor suppressive properties (25, 42, 43) .
The levels of β -MSP in blood are negatively correlated with risk of a prostate cancer diagnosis (44) and positively associated with recurrence-free survival (45). These findings are consistent with a direct role for MSMB in prostate cancer etiology. However, we cannot exclude a potential role for NCOA4, mediated by previously unidentified SNPs in LD with rs10993994, either instead of or in addition to MSMB.
The number of GWAS loci for which causal variants and their downstream effect have been identified using genome editing is relatively limited (9, 11, 12, (14) (15) (16) (17) (18) (19) 46) . One limiting factor is that in many cases, genome editing revealed that the allelic effect on target gene expression is very mild. In contrast, here we have shown extensive overexpression conferred by altering SNP-containing regulatory regions. Second, the low efficiency of homology-directed repair limits large-scale application of CRISPR/Cas9. Our alternative approach of using a paired gRNA system (34, 35) to delete single copies of heterozygous alleles allows us to observe the effect of each variant allele in isolation.
As GWAS have identified numerous genetic polymorphisms associated with increased risk of cancer and other diseases, the next big challenge is to understand how they mediate pathogenesis, especially for regulatory variants. The majority of these variants are found in the non-coding region of the genome(1-3) and enriched in regulatory regions identified by large-scale functional genomics projects including ENCODE, Roadmap Epigenome and FANTOM5(2-6). These observations together with a recent report that 82% of cancers depend on RNA expression level(20) changes indicate the importance of studying the relationship between disease risk variants and gene expression. Our study for the first time demonstrates dramatic cell-specific and gene-specific effect on gene expression mediated by GWAS-identified risk variants and provides an efficient way for further systematic study of the function of other GWAS variants.
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SUPPLEMENTARY DATA
Supplementary Data are available at NAR online.
DATA AVAILABILITY
Cell clones generated in the study are available upon request. Rs7098889 is positioned at chr10:51544475. 
